Harvard Bioscience (HBIO) - Pangali EV/EBITDA

The Harvard Bioscience (HBIO) price chart on the GURU.Markets platform with the 13.18 indicator allows for an assessment of the business's dependence on the demand for high-precision biomedical equipment and order volumes from pharmaceutical behemoths. The company generates revenue through the sale of cell analysis systems and dosing pumps for laboratories. The brand's impeccable reputation among scientists and universities makes the manufacturer's position highly resilient to market volatility.

HBIO Harvard Bioscience: Nilai perusahaan marang bathi operasional sadurunge panyusutan ing interval 23.11.2025 - 10.11.2026

Rincian analitis perusahaan Harvard Bioscience Inc. (HBIO)

- rega saham lan target rega konsensus:

Kutipan saham Harvard Bioscience, Inc.|HBIO - Konsensus nilai wajar

- indikator kapitalisasi pasar:

Kapitalisasi pasar Harvard Bioscience, Inc.|HBIO - Rega Tumbas Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham Harvard Bioscience|HBIO - Kapitalisasi Akuntansi|Rasio Nilai Pasar marang Nilai Buku harvardbioscience.com|HBIO - Gunggung Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Rasio Total Utang marang Ekuitas Harvard Bioscience|HBIO - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang ekuitas Harvard Bioscience|HBIO - Kewajiban utang agregat|Utang marang nilai buku Harvard Bioscience, Inc.|HBIO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Harvard Bioscience|Rasio cepet harvardbioscience.com

- data bathi bisnis lan rasio investasi:

HBIO - Penghasilan resik perusahaan|Bathi sing dikarepake Harvard Bioscience|HBIO - Pangali rega marang bathi|Prakiraan rega marang bathi Harvard Bioscience, Inc.|HBIO - Rasio nilai perusahaan marang wutah bathi|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Harvard Bioscience, Inc.|HBIO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Harvard Bioscience|HBIO - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan harvardbioscience.com|HBIO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Harvard Bioscience

Ringkesan analisis perusahaan:Harvard Bioscience, Inc. (HBIO)

Produk sing diprodhuksi Harvard Bioscience

For the conservative investor, this ratio serves as a key valuation metric, combining market capitalization and net debt relative to earnings before interest, taxes, depreciation, and amortization. By analyzing the EV/EBITDA trajectory of Harvard Bioscience (HBIO), one can assess the stability of HBIO: the low cyclicality of demand for laboratory equipment smooths the volatility of this multiple, confirming the fundamental reliability of the business even under a significant debt load.

Pesaing Harvard Bioscience